SCHEDULE: Vanguard Group Updates Innoviva Ownership Reporting

The Vanguard Group has reported a 0% beneficial ownership in Innoviva Inc. following an internal realignment, disaggregating its reporting.

Summary

• The Vanguard Group filed an Amendment No. 10 to Schedule 13G for Innoviva Inc. common stock.
• The filing indicates that The Vanguard Group now beneficially owns 0 shares of Innoviva Inc., representing 0% of the class.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis).
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Innoviva Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily a technical update regarding The Vanguard Group's internal reporting structure rather than a change in investment sentiment towards Innoviva Inc.

Future Outlook

NA

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that this filing reflects a technical reporting change by a major institutional investor, The Vanguard Group, rather than a strategic divestment based on Innoviva's performance. Such internal realignments are common among large asset managers for operational efficiency or regulatory compliance, and do not necessarily indicate a change in investment thesis for the underlying company by Vanguard's various funds.

Stakeholder Impact

• Shareholders of Innoviva Inc. should note that The Vanguard Group, Inc. itself no longer directly reports beneficial ownership, but its underlying funds and subsidiaries may still hold shares, now reported separately.

Key Dates

Keywords

Innoviva Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Investment Adviser, Common Stock, Disaggregated Reporting